Cover Image for An Evening with Syra Madad and Jacob Glanville
Cover Image for An Evening with Syra Madad and Jacob Glanville

An Evening with Syra Madad and Jacob Glanville

Registration
Approval Required
Your registration is subject to host approval.
Welcome! To join the event, please register below.
About Event

​Join MCBcDNA for a conversation with Syra Madad, Chief Biopreparedness Officer at NYC Health + Hospitals, and Jacob Glanville, CEO and President of Centivax.

​Syra is an infectious disease epidemiologist specializing in outbreak preparedness, emergency response, and biosecurity. She has helped lead responses to major infectious disease threats, including Ebola and COVID-19. Jacob is a biotechnology entrepreneur developing next-generation vaccines and antibody therapeutics, including broad-spectrum approaches to preventing and treating infectious diseases. He previously founded Distributed Bio, which was acquired by Charles River Laboratories in 2020.

​During this evening, we'll explore pandemic preparedness, the science behind next-generation vaccines and therapeutics, and the challenges of responding to emerging infectious disease threats. We'll also discuss how scientific innovation, biotechnology entrepreneurship, and public health collaboration can help protect against future pandemics.

​Agenda

  • ​6:00 PM — Doors open

  • ​6:10–6:15 PM — Welcome & introductions

  • ​6:15–6:30 PM — Presentation from Syra Madad

  • ​6:30–6:45 PM — Presentation from Jacob Glanville

  • ​6:45–7:05 PM — Fireside Chat with Syra and Jacob

  • ​7:05–7:20 PM — Audience Q&A

  • ​7:20–8:00 PM — Networking reception with food & drinks

​Registration & Arrival
Space is limited and registration requires approval. We’ll review registrations on a rolling basis, and you’ll receive a confirmation email once approved. Registration closes Tuesday, October 20.

​Event Sponsor: Cooley
Cooley represents a broad range of high-growth life sciences companies - advising clients at every stage – from early-stage companies in clinical trials and those seeking FDA approval to established businesses with marketed products. Cooley actively represents 2,500+ public and private life sciences company clients worldwide – and counsel nearly 50% of the companies on the Nasdaq Biotechnology Index. Our collaborative approach draws upon unparalleled experience and our extensive industry network to drive strategic solutions and resolve challenges. With Cooley as your catalyst, you’re not just part of the life sciences industry – you’re shaping it.

​Series Partner: Biocom California
Biocom California is the largest life science association in the state, and through its Biocom Institute it works to connect students and emerging talent with careers across biotech and the life sciences. Learn more at biocom.org.

Location
Cooley LLP
3 Embarcadero Ctr 20th Floor, San Francisco, CA 94111, USA